Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high risk PSA recurrent prostate cancer (PC): The STREAM trial.

被引：2

作者：

Armstrong, Andrew J.

Bitting, Rhonda L.

Healy, Patrick

George, Daniel J.

Kim, Sung

Mayer, Tina M.

Winters, Carolyn

Riggan, Colleen

Rasmussen, Julia

Wilder, Rhonda

Anand, Monika

Stein, Mark N.

Frizzell, Bart

Harrison, Michael Roger

Zhang, Tian

Lee, W. Robert

Wu, Yuan

Koontz, Bridget F.

机构：

[1] Duke Canc Inst, Durham, NC USA

[2] Duke Prostate & Urol Canc Ctr, Durham, NC USA

[3] Sect Hematol & Oncol, Internal Med, Winston Salem, NC USA

[4] Duke Univ, Duke Canc Inst, Durham, NC USA

[5] Canc Inst New Jersey, New Brunswick, NJ USA

[6] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA

[7] Duke Univ, Durham, NC USA

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Columbia Univ, Med Ctr, New York, NY USA

[10] High Point Canc Ctr, High Point, NC USA

[11] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA

[12] Duke Canc Inst, Dept Biostat & Bioinformat, Durham, NC USA

来源：

关键词：

D O I：

10.1200/JCO.2019.37.7_suppl.29

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2